Flindr Therapeutics
PrivateLast Round
Series A
Apr 24, 2024
Total Funding Raised
$21.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Flindr Therapeutics operates in Healthcare & Life Sciences and is based in Oss. Its latest recorded funding round was a Series A round in April 2024.
Flindr Therapeutics is a biotechnology company developing a pipeline of first-in-class small molecule inhibitors for the precision treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flindr Therapeutics Comparables
Compare Flindr Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Outrun Therapeutics | 84% | |
| Eisbach Bio GmbH | 78% | |
| Light Horse Therapeutics | 77% |
For institutional investors. Book with your work email.
Flindr Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Flindr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed, Series A |
| Swanbridge Capital | Seed, Series A |
| Innovatiefonds Noord-Holland | Seed |
| V-Bio Ventures | Series A |
| Oncode Institute | Seed, Series A |
| PMV | Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 17% QoQ from 18 to 21 employees.
- Jan 24, 2026
Monthly visitors increased 505% MoM, from 74 to 448.
For institutional investors. Book with your work email.
Flindr Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Flindr Therapeutics's valuation, stock price, and market status.
Is Flindr Therapeutics a public or private company?
Flindr Therapeutics is a private company.
What is the current stock price of Flindr Therapeutics?
Flindr Therapeutics is a private company, so its shares have no public market price. Caplight tracks Flindr Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Flindr Therapeutics worth (valuation)?
Valuation information for Flindr Therapeutics is not publicly available.
Can I buy Flindr Therapeutics stock?
Flindr Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Flindr Therapeutics's last funding round?
Flindr Therapeutics's most recent funding round was Series A on April 24, 2024.
Who are the main investors in Flindr Therapeutics?
Key investors in Flindr Therapeutics include V-Bio Ventures.
Will Flindr Therapeutics IPO soon?
No public IPO plans have been announced for Flindr Therapeutics.
How can I track Flindr Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Flindr Therapeutics's shares on secondary markets.